Literature DB >> 8651700

Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase.

A Taurog1, M L Dorris, D R Doerge.   

Abstract

Thyroid peroxidase (TPO) simultaneously catalyzes two very different types of reaction in the thyroid gland- iodination and coupling. The present study addresses the mechanism of this simultaneous dual activity. Compound I, the two-electron oxidation product of TPO, exists in two different forms--an oxoferryl porphyrin pi-cation radical and an oxoferryl protein radical. It has been proposed that iodination is mediated by the porphyrin pi-cation radical form of TPO compound I, while coupling is mediated by the protein radical form. However, results obtained in the present study favor the view that both iodination and coupling are mediated by the porphyrin pi-cation radical form of compound I. In the first part of the study, we compared coupling and iodination activities of two peroxidases with very similar crystal structures--cytochrome c peroxidase (CcP) and lignin peroxidase (LiP). Although these two peroxidases have very similar three-dimensional structures, CcP forms a compound I only of the protein radical type, whereas compound I of LiP exists only as a porphyrin pi-cation radical. Comparison of the catalytic activities of the two enzymes showed that diiodotyrosine (DIT)-stimulated coupling activity of LiP was significantly greater than that of CcP. Moreover, lignin peroxidase displayed very significant iodinating activity at acid pHs, whereas iodination with CcP was negligible at all pHs tested. Our findings with these two structurally similar peroxidases suggested that TPO-catalyzed iodination and coupling could both be mediated by the porphyrin pi-cation radical form of compound I. More direct evidence in support of this view was obtained in the second part of this study, employing TPO and lactoperoxidase (LPO) model systems in which iodination and coupling occurred simultaneously. Heme spectral analysis was used to correlate formation of the protein radical form of compound I with the kinetics of the iodination and coupling reactions. Formation of the compound I protein radical was not observed until the iodination and coupling reactions had almost been completed. In separate experiments it was shown that the spontaneous conversion of the porphyrin pi-cation radical form of TPO or LPO compound I to the protein radical form was markedly inhibited by a low concentration of iodide, especially in the presence of an iodide acceptor. These studies provide compelling evidence that both iodination and coupling are mediated by the porphyrin pi-cation radical form of compound I. This was further substantiated by the finding that coupling was inhibited in the presence of excess iodide, an observation readily explained by competition between iodide and DIT residues in thyroglobulin for oxidation by the porphyrin pi-cation radical.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651700     DOI: 10.1006/abbi.1996.0222

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

1.  New protein footprinting: fast photochemical iodination combined with top-down and bottom-up mass spectrometry.

Authors:  Jiawei Chen; Weidong Cui; Daryl Giblin; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-06       Impact factor: 3.109

2.  Revisiting iodination sites in thyroglobulin with an organ-oriented shotgun strategy.

Authors:  Alain Dedieu; Jean-Charles Gaillard; Thierry Pourcher; Elisabeth Darrouzet; Jean Armengaud
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

Review 3.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

4.  N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro.

Authors:  Sylvie Poncin; Ides M Colin; Brigitte Decallonne; Isabelle Clinckspooor; Marie-Christine Many; Jean-François Denef; Anne-Catherine Gérard
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

5.  A genome-wide association study on thyroid function and anti-thyroid peroxidase antibodies in Koreans.

Authors:  Soo Heon Kwak; Young Joo Park; Min Jin Go; Kyu Eun Lee; Su-Jin Kim; Hoon Sung Choi; Tae Hyuk Kim; Sung Hee Choi; Soo Lim; Ki Woong Kim; Do Joon Park; Sung Soo Kim; Jong-Young Lee; Kyong Soo Park; Hak C Jang; Nam H Cho
Journal:  Hum Mol Genet       Date:  2014-04-09       Impact factor: 6.150

6.  Targeted Pathway-based In Vivo Testing Using Thyroperoxidase Inhibition to Evaluate Plasma Thyroxine as a Surrogate Metric of Metamorphic Success in Model Amphibian Xenopus laevis.

Authors:  Jonathan T Haselman; Jennifer H Olker; Patricia A Kosian; Joseph J Korte; Joseph A Swintek; Jeffrey S Denny; John W Nichols; Joseph E Tietge; Michael W Hornung; Sigmund J Degitz
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

7.  Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.

Authors:  Svetlana Savin; Dubravka Cvejic; Tijana Isic; Ivana Petrovic; Ivan Paunovic; Svetislav Tatic; Marija Havelka
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 8.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

9.  Vascular peroxidase 1 catalyzes the formation of hypohalous acids: characterization of its substrate specificity and enzymatic properties.

Authors:  Hong Li; Zehong Cao; Guogang Zhang; Victor J Thannickal; Guangjie Cheng
Journal:  Free Radic Biol Med       Date:  2012-09-12       Impact factor: 7.376

10.  Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.

Authors:  Katie Paul Friedman; Eric D Watt; Michael W Hornung; Joan M Hedge; Richard S Judson; Kevin M Crofton; Keith A Houck; Steven O Simmons
Journal:  Toxicol Sci       Date:  2016-02-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.